
Misook Yu
Supervisory Patent Examiner (ID: 1022, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 859 |
| Issued Applications | 261 |
| Pending Applications | 201 |
| Abandoned Applications | 403 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 620003
[patent_doc_number] => 07141435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-28
[patent_title] => 'Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP'
[patent_app_type] => utility
[patent_app_number] => 10/285408
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5870
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/141/07141435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10285408
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/285408 | Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP | Oct 31, 2002 | Issued |
Array
(
[id] => 7024947
[patent_doc_number] => 20050019341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Tumor antigen'
[patent_app_type] => utility
[patent_app_number] => 10/494069
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16883
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494069 | Tumor antigen | Oct 28, 2002 | Abandoned |
Array
(
[id] => 672037
[patent_doc_number] => 07091047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-15
[patent_title] => 'Methods and kits for diagnosing tumorigenicity'
[patent_app_type] => utility
[patent_app_number] => 10/281160
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 14079
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10281160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/281160 | Methods and kits for diagnosing tumorigenicity | Oct 27, 2002 | Issued |
Array
(
[id] => 6856130
[patent_doc_number] => 20030129631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Gene family with transformation modulating activity'
[patent_app_type] => new
[patent_app_number] => 10/273334
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16240
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10273334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/273334 | Gene family with transformation modulating activity | Oct 17, 2002 | Abandoned |
Array
(
[id] => 7463070
[patent_doc_number] => 20040053228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same'
[patent_app_type] => new
[patent_app_number] => 10/148953
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6808
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148953 | Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same | Oct 15, 2002 | Abandoned |
Array
(
[id] => 6856128
[patent_doc_number] => 20030129629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Methods and compositions for the identification, assessment, prevention, and therapy of human cancers'
[patent_app_type] => new
[patent_app_number] => 10/272111
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50320
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10272111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/272111 | Methods and compositions for the identification, assessment, prevention, and therapy of human cancers | Oct 15, 2002 | Abandoned |
Array
(
[id] => 536500
[patent_doc_number] => 07173112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-06
[patent_title] => 'Antibody to GALP and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/490917
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 14618
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/173/07173112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490917 | Antibody to GALP and uses thereof | Sep 24, 2002 | Issued |
Array
(
[id] => 6692649
[patent_doc_number] => 20030040081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Galectin 9 and 10SV polynucleotides'
[patent_app_type] => new
[patent_app_number] => 10/235674
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16820
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040081.pdf
[firstpage_image] =>[orig_patent_app_number] => 10235674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/235674 | Galectin 9 and 10SV polynucleotides | Sep 5, 2002 | Abandoned |
Array
(
[id] => 7175752
[patent_doc_number] => 20050123476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases'
[patent_app_type] => utility
[patent_app_number] => 10/488806
[patent_app_country] => US
[patent_app_date] => 2002-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39029
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488806 | Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases | Sep 4, 2002 | Abandoned |
Array
(
[id] => 6865179
[patent_doc_number] => 20030190705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Method of humanizing immune system molecules'
[patent_app_type] => new
[patent_app_number] => 10/230880
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 29527
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190705.pdf
[firstpage_image] =>[orig_patent_app_number] => 10230880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/230880 | Method of humanizing immune system molecules | Aug 28, 2002 | Abandoned |
Array
(
[id] => 6869914
[patent_doc_number] => 20030082603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Colon cancer marker'
[patent_app_type] => new
[patent_app_number] => 10/232803
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 18244
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082603.pdf
[firstpage_image] =>[orig_patent_app_number] => 10232803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/232803 | Colon cancer marker | Aug 28, 2002 | Abandoned |
Array
(
[id] => 6861653
[patent_doc_number] => 20030092661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => '88kDa tumorigenic growth factor and antagonists'
[patent_app_type] => new
[patent_app_number] => 10/218509
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 20752
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218509
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218509 | 88kDa tumorigenic growth factor and antagonists | Aug 14, 2002 | Abandoned |
Array
(
[id] => 6642592
[patent_doc_number] => 20030103976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Anti-fas antibodies'
[patent_app_type] => new
[patent_app_number] => 10/216484
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 68396
[patent_no_of_claims] => 119
[patent_no_of_ind_claims] => 48
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103976.pdf
[firstpage_image] =>[orig_patent_app_number] => 10216484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/216484 | Anti-fas antibodies | Aug 8, 2002 | Abandoned |
Array
(
[id] => 330212
[patent_doc_number] => 07510707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'PAR, a novel marker gene for breast and prostate cancers'
[patent_app_type] => utility
[patent_app_number] => 10/178389
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9204
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/510/07510707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178389 | PAR, a novel marker gene for breast and prostate cancers | Jun 23, 2002 | Issued |
Array
(
[id] => 6783581
[patent_doc_number] => 20030065029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Agent for diagnosing and treating malignant tumors'
[patent_app_type] => new
[patent_app_number] => 10/174823
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5293
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20030065029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174823 | Agent for diagnosing and treating malignant tumors | Jun 19, 2002 | Issued |
Array
(
[id] => 6735158
[patent_doc_number] => 20030012793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Compositions and methods for promoting tissue repair using heat shock proteins'
[patent_app_type] => new
[patent_app_number] => 10/174786
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12946
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012793.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174786 | Compositions and methods for promoting tissue repair using heat shock proteins | Jun 17, 2002 | Abandoned |
Array
(
[id] => 6650884
[patent_doc_number] => 20030008370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => '13295 novel protein kinase molecules and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/172088
[patent_app_country] => US
[patent_app_date] => 2002-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31529
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10172088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/172088 | 13295 novel protein kinase molecules and uses therefor | Jun 12, 2002 | Abandoned |
Array
(
[id] => 6735141
[patent_doc_number] => 20030012776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Nucleic acid and protein expressed thereby and their involvement in stress'
[patent_app_type] => new
[patent_app_number] => 10/164359
[patent_app_country] => US
[patent_app_date] => 2002-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12509
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10164359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/164359 | Nucleic acid and protein expression thereby and their involvement in stress | Jun 5, 2002 | Issued |
Array
(
[id] => 5843023
[patent_doc_number] => 20060121457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Gfats as modifiers of the p53 pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/480021
[patent_app_country] => US
[patent_app_date] => 2002-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13395
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480021 | Gfats as modifiers of the p53 pathway and methods of use | Jun 1, 2002 | Abandoned |
Array
(
[id] => 4664432
[patent_doc_number] => 20080255339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities'
[patent_app_type] => utility
[patent_app_number] => 10/156920
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11663
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10156920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/156920 | Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities | May 28, 2002 | Abandoned |